Ọgwụ "Tizanil": ntuziaka maka ojiji, analogs na reviews

"Tizanil" - a muscle relaxant, na-enye Central edinam. Iji belata ụda skeletal uru na-eji ọgwụ "Tizanil" na-egosi maka ojiji nke ka, ma ọ bụrụ na ọ dị mkpa, kpochapụ muscle apịajighị apịaji na-enweta site na mmepe nke akwara ozi ọrịa, degenerative diski ọrịa, ịwa ahụ ma ọ bụ mmerụ. E wezụga n'ọrụ mgwa tizanidine, na agwọ ọrịa mejupụtara ọzọ mmiri. Inyeaka mmetụta bụ n'ihi na ọnụnọ nke sịlịkọn dioxide, stearic acid, microcrystalline cellulose na lactose monohydrate.

Pharmacological edinam "Tizanila"

Alpha2-adrenergic anabata na-arụ ọrụ mgbe na-anata a "Tizanil" n'aka. The mejupụtara nke Nwa nwere ike n'ụzọ dị irè-emeso acutely gosipụtara cramps na apịajighị apịaji na-adịghị ala ala ụdị, onye si malite bụ ọrịa ụbụrụ ma ọ bụ ọkpụkpụ azụ. Nke a gị n'ụlọnga na-enyere aka belata muscle eguzogide n'oge nnabata mmegharị na-amụba aka ike muscular contractions.

Absorption nke ọgwụ na-adị ngwa ngwa. "Tizanil" ntuziaka maka ojiji bụ dị ka a ngwá ọrụ na-etinye obi gị dum fọrọ nke nta kpamkpam na karịa ego dị na ọbara 60 nkeji mgbe abanye digestive tract.

Metabolism pụtara na imeju, na bioavailability kwekọrọ na 34% nkịtị ka plasma protein - 30%. Nke ọkara ndụ na-ewe nkezi nke awa atọ. The ọgwụ na-anyụpụ si ahụ ka metabolites tumadi akụrụ, ya obere akụkụ a na-ewepụ na-emebibeghị.

na-agba akaebe

Pụtara n'ihi na "Tizanil" na-egosi maka ojiji ndị dị ka ndị:

• ọkpụkpụ azụ ọrịa na muscle apịajighị apịaji, nke na-ebu ihe mgbu;
• na-egbu mgbu muscle apịajighị apịaji mgbe ịwa ahụ;
• skeletal muscle spasticity dị ka a n'ihi nke akwara ozi ọrịa.

Contraindications inweta "Tizanila"

Ọgwụ contraindicated na hypersensitivity ka ya mmiri, ọrịa nke imeju na-na akụrụ, ebe akpọ. "Tizanil" ntụziaka adịghị ekwe ka itinye oge nke gestation nke nwa na ara udia ya. Contraindication bụ ọgwụgwọ nke "fluvoxamine". Age-erughị afọ 18, na-emetụta contraindications.

Na gbasara akụrụ insufficiency, ntụziaka na-enye ohere maka ojiji nke ọgwụ, ma na oké ịkpachara anya. The otu na-emetụta nkwonkwo eji "Tizanila" na CYP1A2 inhibitors na ọgwụgwọ na ndị agadi.

Ngwa agwọ ọrịa onunu ogwu

The na nkà mmụta ọgwụ e ji ọnụ na. Ọ bụrụ na nzube nke ojiji nke ọgwụ bụ iwepụ na-egbu mgbu muscle apịajighị apịaji, ọ na-atụ aro iji a dose sitere na site 2 4 mg. The na-atụ aro dose nke mmadụ kwesịrị iwere ugboro atọ n'ụbọchị. Ọ bụrụ na a ikpe bụ arọ, na ọ na-ekwe ka tinye a n'ihu supplementation nke 2-4 mg nke agwọ ọrịa "Tizanil". The mbadamba dị ka ngwa ndu nwere ike ga-eji na skeletal muscle spasticity 6mg. Nke a bụ karịa kwa ụbọchị onunu ogwu, nke na mbụ ogbo nke ọgwụgwọ na-ekwesịghị karịa. N'ịgwọ ọnọdụ ndị dị otú a na-rụrụ site na atọ kwa ụbọchị dosing. Idebe ihe ndị nkeji nke 3-7 ụbọchị, dose nwere ike jiri nwayọọ nwayọọ mụbara site na nkezi nke 3 mg.

Nke kacha mmetụta, na-eweta kwere kwa ụbọchị dose 24 mg. The kacha onunu ogwu bụ n'ozuzu 12 mg ma ọ bụ karịa, ma ike gafere 36 mg. N'ihi ya kwa ụbọchị ga-rụrụ 3 ma ọ bụ 4 ndibọbọ pụtara "Tizanil". Ntuziaka maka ojiji e dere ozi na ọgwụgwọ nke ọrịa na gbasara akụrụ insufficiency. Ndị dị otú ahụ ọrịa ibido kenyere ọgwụ maka ojiji otu ugboro n'ụbọchị na a kacha nta dose kwekọrọ 2 mg. The onunu ogwu na-eji nwayọọ nwayọọ gbanwere na mmeghachi omume nke onye ọrịa. Ọ bụrụ na ị chọrọ dịkwuo dose, ịba ụba nke mbụ dose, na mgbe ahụ na-agbanwe nọmba nke intakes.

mmetụta

Ogologo okwu ọgwụgwọ a na mgbe ụfọdụ, esonyere ekwesighi Jeremaya mere nke organism. Na nke a, ha nwere ike imepe ọzọ na-egosi ndị ọzọ akpọ. A na-emetụta n'ikuku nke nnukwu doses nke "Tizanil" ọgwụ ọjọọ. Ntuziaka maka ojiji Dị ka a mmetụta, dị ka a malfunction nke eriri afọ tract, ihicha nke mucous akpụkpọ ahụ ọnụ, na-abaghị ọnụ ke ọbara mgbali, ike ọgwụgwụ, iro ụra, dizziness na ndị ọzọ oghom ihe.

Ntoputa nke mmetụta bụ a mere ọgwụgwọ na nke dọkịta, nke ma belata dose ma ọ bụ kagbuo ọgwụ, dochie ya n'ụzọ ndị ọzọ. Na ọgwụgwọ ọgwụ "Tizanil" ntuziaka maka ojiji nwere na-kwuru na ihe ize ndụ nke mmetụta na-ebelata.

ọgwụ interactions

The na mmekọrịta nke dị iche iche ọgwụ - a dị ezigbo mkpa ozi, nke a ga-atụle tupu ọgwụgwọ iji belata likelihood nke mmetụta, wezụga-emebi ahụ, ma belata ihe ize ndụ nke irè nke ọgwụ.

Ọ maara na ọgwụ "Tizanil" jikọtara "Fluvoxamine", na-eduga ná ndakpọ nke ahụ ike. Mgbe ọ na-concomitantly na antihypertensive ọgwụ ọjọọ pụrụ ịzụlite bradycardia na hypotension.

Ọ bụrụ na ma ethanol ma ọ bụ sedatives na mbadamba "Tizanil" ntụziaka na-egosi onye na-abawanye na ogwuura, nke a na-nyere "Tizanilom". Na ya Nchikota na onu gbochie afọ nwere ike imebi adịm nwechapụ ọkara.

Drug interactions nwere ike ịgbanwe nrụpụta ọrụ nke ọgwụgwọ. Na n'otu oge iji ọtụtụ ọgwụ ọjọọ eme, ha nwere ike welie mmetụta nke onye ọ bụla ọzọ ma ọ bụ akụda. All nke a bụ fraught na ọdịdị oghom Jeremaya mere, ovadozu, na-enweghị ndị dị mkpa N'ihi.

adọ aka ná ntị

Tupu ịmalite ọgwụgwọ na "Tizanil"-egosi na contraindications ga-nlezianya mụọ.

Ọ kọrọ omume nke oghom mgbanwe akụrụ na imeju. Ma ọgwụ dabeere na-ewere ọgwụ na a dose nke 12 mg ma ọ bụ obere, dị otú ahụ ikpe nnọọ obere.

Ọ na-gwara oge buru imeju ọrụ ule. N'oge ọnwa anọ ndị mbụ - a ọnwa ozugbo. Na ọnọdụ ebe ndị AST na Alt etoju n'ofè nkịtị ụkpụrụ budata gafere ha, na-achọ-ekpochapụ nke ọgwụ.

Ụfọdụ ọrịa ndị na-ewe "Tizanil" (gụnyere analogs) Ọ pụrụ isi ike iro ụra. Mgbe na steeti a, i nwere ike na-eme mmemme nke chọrọ ka-elekwasị anya na ngwa ngwa ndị Jeremaya mere.

N'ihi iyi egwu nke na-arịa ọrịa ọrịa ọgwụ na-adịghị kagbuo inikiet inikiet, ọ na-gbahapụrụ gradual dose Mbelata.

Analogs "Tizanila"

Kenyere na ntuziaka ka ihe owuwu "Tizanil" na ịgụ ihe na-ekwe mgbe nile ka ị na-iji na mbụ n'ihi na nke ụfọdụ contraindications. The kasị oké ọnụ ọgwụ ọjọọ eme ihe bụ nke "tizanidine-Teva" na "Tizalud". Ọgwụ ndị a na-relaxants, dị na mbadamba ụdị nwere otu n'ọrụ mgwa.

Arụpụtara ndị ọzọ analogs. Ka ihe atụ, omume nwere ike ịbụ "Mydocalm", "Teva-Tizanilom" Surdaludom MR "," Surdaludom ".

Nyocha

Nyocha nke "Tizanile" dị iche iche, ie. Iji. The ọgwụ pụrụ imetụta ọrịa dị iche iche. Ma ukwuu n'ime ha nke oma. Nke a owuwu bidoro ibipụta ruo ogologo oge, ọ bụ na-ere maka a ogologo oge, ọtụtụ ndị enwewo ike iji hụ na ya irè. E nwere ọjọọ reviews ekpe n'ihi oghom mmetụta n'ihi ekweghị ibe nọrọ nke mmiri ma ọ bụ ojiji nke elu doses akwadoro maka ọgwụgwọ nke "Tizanil" ọgwụ ọjọọ. Positive reviews hapụrụ ndị na-enwe obi ụtọ na N'ihi ya, na ọgwụgwọ usoro soro usoro onunu ogwu kenyere dọkịta, na fọrọ nke nta na-adịghị ama mgbe ọ bụla iwe.

a ọgwụ na-eji na-emeso degenerative diski ọrịa. Ekele ya edinam mgbaàmà na-eso ndị ọrịa na-apụ n'anya ngwa ngwa. Gafere isi ọwụwa na azụ mgbu, mma n'ozuzu ike. Mgbe ụfọdụ, e nwere obere mmetụta dị otú ahụ dị ka iro ụra, nkụ nke onu mucosa, ma na kwesịrị ekwesị ukpụhọde nke dose ma ọ bụ ndọrọ ego nke ọgwụ ha na-apụ n'anya. Ụfọdụ ọrịa na nnukwu eru osteochondrosis, akpasu radicular syndrome, ya bụ "Tizanil" laghachiri nkịtị agagharị, mgbe ọgwụ ndị ọzọ emeghị ka chọrọ na-arụpụta.

The ọgwụ ọ bụghị ihe ọjọọ na-ewepu elu muscle ụda, nke ghọọ a N'ihi ya nke a na ọrịa strok. "Tizanil" iwere na na ndenye ọgwụ na ọnụnọ nke kwesịrị ekwesị na-egosi. Ọ bụrụ na ọgwụgwọ a chọrọ agadi onye ma ọ bụ onye ọrịa ya na a ọrịa imeju, na ọ bụ mma ghara n'ihe ize ndụ ahụ ike na-ahọrọ a dị iche iche muscle relaxant, nke nwekwara si anagide ọma na ihe aga-eme.